opti-free
Novartis Spending $39 Billion for Alcon
Read the full article: http://biz.yahoo.com/ap/080407/switzerland_novartis_alcon.ht...
Switzerland's Novartis said Monday it will spend about $39 billion in a two-step bid for a majority stake in U.S. eye-care company Alcon.
The deal for Alcon Inc., which makes Opti-Free contact lens solution and has 14,500 employees worldwide, would be one of the largest in Swiss history.
Vested Interest:
None listed- Login or register to post comments
- Read more
- Email this page
Related Articles
- Novartis Spending $39 Billion for Alcon
- Dyax Corp. (DYAX) Announces Completion of Biologics License Application with FDA; Moves Forward with Treatment for Life-Threaten
- Obama or McCain: Who?s Better for Healthcare Investors?
- Nutrition 21 Inc. (NXXI) Reports That National Toxicology Program Studies Support the Safety of Chromium Picolinate
- Patient Portal Inc. (PPRG.OB) Second Quarter Margins Increase 25.5%, Receives 6 Year Digital Services Contract
